2018
DOI: 10.1016/j.ymben.2018.07.001
|View full text |Cite
|
Sign up to set email alerts
|

CasPER, a method for directed evolution in genomic contexts using mutagenesis and CRISPR/Cas9

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
37
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 63 publications
(41 citation statements)
references
References 69 publications
1
37
1
Order By: Relevance
“…This plasmid pool was then used to create a genome-wide gene disruption collection, in which more than 98% of target sequences were efficiently edited with an average Increased by 3-fold with a specific titer of octadocanol at 10.3 mg/g DCW Kaczmarzyk et al, 2018 Ustilago maydis CRISPR/Cas9 Itaconic acid cyp3, MEL, UA, and P ria1 ::P etef Increased by 10.2-fold with a yield at 19.4 g/L and further enhanced to 53.5 g/L under optimized medium Becker et al, 2019 frequency of 82% (Bao et al, 2018). In parallel, Jakociunas et al employed error-prone PCR to generate DNA mutant libraries as donor, and used Cas9-mediated genome integration to introduce mutations at single-or multi-loci with efficiencies reaching 98-99%, for robust directed evolution (Jakociunas et al, 2018b). Besides, large chromosomal fragment deletion methods were developed based on CRISPR/Cas9 system.…”
Section: Promotion Of Crispr/cas System For Multi-loci Editingmentioning
confidence: 99%
See 2 more Smart Citations
“…This plasmid pool was then used to create a genome-wide gene disruption collection, in which more than 98% of target sequences were efficiently edited with an average Increased by 3-fold with a specific titer of octadocanol at 10.3 mg/g DCW Kaczmarzyk et al, 2018 Ustilago maydis CRISPR/Cas9 Itaconic acid cyp3, MEL, UA, and P ria1 ::P etef Increased by 10.2-fold with a yield at 19.4 g/L and further enhanced to 53.5 g/L under optimized medium Becker et al, 2019 frequency of 82% (Bao et al, 2018). In parallel, Jakociunas et al employed error-prone PCR to generate DNA mutant libraries as donor, and used Cas9-mediated genome integration to introduce mutations at single-or multi-loci with efficiencies reaching 98-99%, for robust directed evolution (Jakociunas et al, 2018b). Besides, large chromosomal fragment deletion methods were developed based on CRISPR/Cas9 system.…”
Section: Promotion Of Crispr/cas System For Multi-loci Editingmentioning
confidence: 99%
“…This plasmid pool was then used to create a genome-wide gene disruption collection, in which more than 98% of target sequences were efficiently edited with an average frequency of 82% ( Bao et al, 2018 ). In parallel, Jakociunas et al employed error-prone PCR to generate DNA mutant libraries as donor, and used Cas9-mediated genome integration to introduce mutations at single- or multi-loci with efficiencies reaching 98-99%, for robust directed evolution ( Jakociunas et al, 2018b ). Besides, large chromosomal fragment deletion methods were developed based on CRISPR/Cas9 system.…”
Section: Application Of Crispr/cas System In Microbial Biotechnologymentioning
confidence: 99%
See 1 more Smart Citation
“…; Jakočiūnas et al. ) could also be utilized for genetic barcoding projects. Because most current genome‐editing approaches require the manipulation of zygotes, the technology will primarily be applicable to species for which gametes can be collected, fertilized, and the resulting offspring grown to maturation in the wild or in captivity.…”
Section: Genome Editing In Organismsmentioning
confidence: 99%
“…Together with large pooled single-guide RNA (sgRNA) libraries, CRISPR-Cas proteins or fusion proteins coupled with the effectors can serve as screening tools [121], such as screening cancer-related genomic ribonucleotides [122], identifying fetal hemoglobin regulator [123] and so on. The CRISPR-Cas system can also serve as a nucleic acid mutation toolkit [124]. Taking advantages of the CRISPR system, researchers can create recording tools [125] and evolutional tools with nCas9 (D10A) combined with the fidelity-reduced Escherichia coli DNA polymerase I [126].…”
Section: Development Of Crispr Systemsmentioning
confidence: 99%